The global molecular cytogenetics market is estimated to grow at a CAGR of more than 6% during the forecast period. The major factors contributing to the growth of the market include a significant prevalence of cancer and increasing demand for genetic testing tools. As per the World Health Organization (WHO), the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. 43.8 million persons were living with cancer in 2018 who were diagnosed within the last 5 years. This rising prevalence of cancer is attributing to the demand for molecular cytogenetic tools.